A detailed history of Portside Wealth Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Portside Wealth Group, LLC holds 32,668 shares of ABT stock, worth $4.25 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
32,668
Previous 44,711 26.94%
Holding current value
$4.25 Million
Previous $6.08 Billion 28.05%
% of portfolio
0.6%
Previous 0.9%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$120.51 - $136.62 $1.45 Million - $1.65 Million
-12,043 Reduced 26.94%
32,668 $4.38 Billion
Q2 2025

Aug 11, 2025

SELL
$123.95 - $138.08 $64,082 - $71,387
-517 Reduced 1.14%
44,711 $6.08 Billion
Q1 2025

Apr 14, 2025

SELL
$111.1 - $140.22 $124,987 - $157,747
-1,125 Reduced 2.43%
45,228 $6 Billion
Q1 2025

Apr 10, 2025

SELL
$111.1 - $140.22 $307,858 - $388,549
-2,771 Reduced 5.63%
46,422 $5.25 Billion
Q4 2024

Apr 14, 2025

SELL
$111.93 - $119.39 $7,723 - $8,237
-69 Reduced 0.15%
46,353 $5.24 Billion
Q4 2024

Jan 15, 2025

SELL
$111.93 - $119.39 $61,449 - $65,545
-549 Reduced 1.1%
49,193 $5.61 Billion
Q3 2024

Oct 31, 2024

BUY
$100.07 - $118.13 $48,734 - $57,529
487 Added 0.99%
49,742 $5.67 Billion
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $225,937 - $252,202
-2,243 Reduced 4.36%
49,255 $5.12 Billion
Q1 2024

Apr 17, 2024

BUY
$109.52 - $120.96 $829,175 - $915,788
7,571 Added 17.24%
51,498 $5.85 Billion
Q4 2023

Jan 16, 2024

SELL
$90.19 - $110.4 $378,798 - $463,680
-4,200 Reduced 8.73%
43,927 $4.84 Billion
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $2,388 - $2,865
-25 Reduced 0.05%
48,127 $4.67 Billion
Q2 2023

Sep 01, 2023

SELL
$100.78 - $112.29 $229 Million - $255 Million
-2,268,808 Reduced 97.92%
48,152 $5.25 Billion
Q2 2023

Aug 01, 2023

BUY
$100.78 - $112.29 $234 Million - $260 Million
2,316,960 New
2,316,960 $253 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Portside Wealth Group, LLC Portfolio

Follow Portside Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portside Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portside Wealth Group, LLC with notifications on news.